Regenerative Medicine Market - Forecasts from 2019 to 2024
The global regenerative medicine market is expected to grow at a CAGR of 6.24% to reach a total market size of US59.482$ billion by 2024, increasing from US$41.364 billion in 2018. Regenerative drugs or medicines are used to heal body tissues or organs from within. The process is called rejuvenation in which these medicines repair the damaged body organs which otherwise cannot heal naturally.
Regenerative medicines also help in replacement where healthy cells, tissues or organs are used from a dead or healthy donor to replace damaged cells, tissues or organs. The other way to heal damaged tissue by these medicines is by delivering healthy cells or tissues to diseased or damaged cells in order to retain body’s normal functioning which is known as regeneration.
Rising government investments in regenerative medicine research are considered as key drivers for the growth of the market during the forecast period. In addition increasing number of product approvals coupled with growing pipeline of regenerative medicine products will further propel the market growth opportunities in the coming years.
The Regenerative Medicine Market – Forecasts from 2019 to 2024” is an exhaustive study that aims to present the key market trends through various chapters focusing on different aspects of the market. The study provides a detailed market overview through the market dynamics sections which detail key market, drivers, restraints, and opportunities in the current market. The report analyzes key opportunity regional markets, and the current technology penetration through lifecycle analysis. The report also analyzes the market through comprehensive market segmentation by type, application, End User and geography.
Based on type, the market has been segmented as Stem cell Therapy, Gene Therapy, Tissue Engineering, and Small Molecules & Biologics. On the basis of application, global regenerative drug market is segmented as cardiovascular, oncology, dermatology, musculoskeletal and others. End-users of global regenerative drugs market include hospitals, biomedical laboratories, and research centers.
Regional analysis has been provided with detailed analysis and forecast for the period 2019 to 2024. The global market has been broken down into North America, South America, Europe, Middle East and Africa, and Asia Pacific regions. The report also analyzes major countries across these regions with thorough analysis and forecast along with prevailing market trends and opportunities which each of these countries present for the manufacturers.
Major players in the regenerative medicine market have been covered along with their relative competitive position and strategies. The report also mentions recent deals and investments of different market players over the last year. The company profiles section details the business overview, financial performance for the past three years, key products and services being offered along with the recent developments of these important players in regenerative medicine market.
Segmentation:
Regenerative medicines also help in replacement where healthy cells, tissues or organs are used from a dead or healthy donor to replace damaged cells, tissues or organs. The other way to heal damaged tissue by these medicines is by delivering healthy cells or tissues to diseased or damaged cells in order to retain body’s normal functioning which is known as regeneration.
Rising government investments in regenerative medicine research are considered as key drivers for the growth of the market during the forecast period. In addition increasing number of product approvals coupled with growing pipeline of regenerative medicine products will further propel the market growth opportunities in the coming years.
The Regenerative Medicine Market – Forecasts from 2019 to 2024” is an exhaustive study that aims to present the key market trends through various chapters focusing on different aspects of the market. The study provides a detailed market overview through the market dynamics sections which detail key market, drivers, restraints, and opportunities in the current market. The report analyzes key opportunity regional markets, and the current technology penetration through lifecycle analysis. The report also analyzes the market through comprehensive market segmentation by type, application, End User and geography.
Based on type, the market has been segmented as Stem cell Therapy, Gene Therapy, Tissue Engineering, and Small Molecules & Biologics. On the basis of application, global regenerative drug market is segmented as cardiovascular, oncology, dermatology, musculoskeletal and others. End-users of global regenerative drugs market include hospitals, biomedical laboratories, and research centers.
Regional analysis has been provided with detailed analysis and forecast for the period 2019 to 2024. The global market has been broken down into North America, South America, Europe, Middle East and Africa, and Asia Pacific regions. The report also analyzes major countries across these regions with thorough analysis and forecast along with prevailing market trends and opportunities which each of these countries present for the manufacturers.
Major players in the regenerative medicine market have been covered along with their relative competitive position and strategies. The report also mentions recent deals and investments of different market players over the last year. The company profiles section details the business overview, financial performance for the past three years, key products and services being offered along with the recent developments of these important players in regenerative medicine market.
Segmentation:
- By Type
- Stem cell Therapy
- Gene Therapy
- Tissue Engineering
- Small Molecules & Biologics
- By Application
- Cardiovascular
- Oncology
- Dermatology
- Musculoskeletal
- Others
- By End user
- Hospitals
- Biomedical laboratories
- Research centers
- By Geography
- North America
- USA
- Canada
- Mexico
- South America
- Brazil
- Argentina
- Others
- Europe
- UK
- Germany
- Italy
- Spain
- Others
- Middle East and Africa (MEA)
- Israel
- Saudi Arabia
- Others
- Asia Pacific (APAC)
- China
- Japan
- India
- Australia
- Others
1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the study
1.4. Currency
1.5. Assumptions
1.6. Base, and Forecast Years Timeline
2. RESEARCH METHODO LOGY
2.1. Research Design
2.2. Secondary Sources
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness
5. REGENERATIVE MEDICINE MARKET BY TYPE
5.1. Stem cell Therapy
5.2. Gene Therapy
5.3. Tissue Engineering
5.4. Small Molecules & Biologics
6. REGENERATIVE MEDICINE MARKET BY APPLICATION
6.1. Cardiovascular
6.2. Oncology
6.3. Dermatology
6.4. Musculoskeletal
6.5. Others
7. REGENERATIVE MEDICINE MARKET BY END USER
7.1. Hospitals
7.2. Biomedical laboratories
7.3. Research centers
8. REGENERATIVE MEDICINE MARKET BY GEOGRAPHY
8.1. North America
8.1.1. USA
8.1.2. Canada
8.1.3. Mexico
8.2. South America
8.2.1. Brazil
8.2.2. Argentina
8.2.3. Others
8.3. Europe
8.3.1. UK
8.3.2. Germany
8.3.3. Italy
8.3.4. Spain
8.3.5. Others
8.4. Middle East and Africa
8.4.1. Israel
8.4.2. Saudi Arabia
8.4.3. Others
8.5. Asia Pacific
8.5.1. China
8.5.2. Japan
8.5.3. India
8.5.4. Australia
8.5.5. Others
9. COMPETITIVE INTELLIGENCE
9.1. Competitive Benchmarking and Analysis
9.2. Strategies of Key Players
9.3. Recent Investments and Deals
10. COMPANY PROFILE
10.1. Novartis
10.2. Amgen
10.3. Bluebird Bio
10.4. Glaxosmithkline
10.5. Shenzhen Sibiono Genetech
10.6. Spark Therapeutics
10.7. Anterogen
10.8. Chiesi Farmaceutici
10.9. Jcr Pharmaceuticals Co Ltd
10.10. Nipro Corp
List of Figures
List of Tables
Disclaimer
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the study
1.4. Currency
1.5. Assumptions
1.6. Base, and Forecast Years Timeline
2. RESEARCH METHODO LOGY
2.1. Research Design
2.2. Secondary Sources
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness
5. REGENERATIVE MEDICINE MARKET BY TYPE
5.1. Stem cell Therapy
5.2. Gene Therapy
5.3. Tissue Engineering
5.4. Small Molecules & Biologics
6. REGENERATIVE MEDICINE MARKET BY APPLICATION
6.1. Cardiovascular
6.2. Oncology
6.3. Dermatology
6.4. Musculoskeletal
6.5. Others
7. REGENERATIVE MEDICINE MARKET BY END USER
7.1. Hospitals
7.2. Biomedical laboratories
7.3. Research centers
8. REGENERATIVE MEDICINE MARKET BY GEOGRAPHY
8.1. North America
8.1.1. USA
8.1.2. Canada
8.1.3. Mexico
8.2. South America
8.2.1. Brazil
8.2.2. Argentina
8.2.3. Others
8.3. Europe
8.3.1. UK
8.3.2. Germany
8.3.3. Italy
8.3.4. Spain
8.3.5. Others
8.4. Middle East and Africa
8.4.1. Israel
8.4.2. Saudi Arabia
8.4.3. Others
8.5. Asia Pacific
8.5.1. China
8.5.2. Japan
8.5.3. India
8.5.4. Australia
8.5.5. Others
9. COMPETITIVE INTELLIGENCE
9.1. Competitive Benchmarking and Analysis
9.2. Strategies of Key Players
9.3. Recent Investments and Deals
10. COMPANY PROFILE
10.1. Novartis
10.2. Amgen
10.3. Bluebird Bio
10.4. Glaxosmithkline
10.5. Shenzhen Sibiono Genetech
10.6. Spark Therapeutics
10.7. Anterogen
10.8. Chiesi Farmaceutici
10.9. Jcr Pharmaceuticals Co Ltd
10.10. Nipro Corp
List of Figures
List of Tables
Disclaimer
